We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA wants to prohibit certain cattle material from drugs, biologics and medical devices to lower the risk of bovine spongiform encephalopathy (BSE or mad cow disease.)
Genentech warned healthcare providers in a letter that use of eye drug Lucentis may increase the risk of stroke, particularly in patients who have already experienced a stroke.
Medtronic’s Physio-Control business has suspended U.S. shipments of external defibrillators and other products from its Redmond, Wash., facility in a move that could allow rival devicemakers to gain market share.
A blood test for coronary heart disease (CHD) could help predict which patients are at higher risk than others for adverse cardiovascular events or death, according to a study in the Jan. 10 issue of The Journal of the American Medical Association.
Two drugs used to treat Parkinson’s disease may increase the risk for heart valve damage, according to two studies published in the New England Journal of Medicine (NEJM).
A Swiss study published Jan. 2 in the Journal of the American College of Cardiology (JACC) found that “collateral function” — the functioning of small “collateral” heart vessels — is more severely impaired in patients implanted with drug-eluting stents than in those implanted with bare-metal stents six months after implantation.
In a slight concession to the medical device industry, the European Parliament last month agreed to delay a proposed ban on mercury-containing sphygmomanometers (blood pressure monitors) while the European Commission conducts a review into safer and reliable alternatives.
After examining risks related to the off-label use of drug-eluting stents, an FDA panel has recommended the agency consider mandating labeling changes.
As information technology (IT) becomes integral in medical device design, clinical and IT specialists need better communication during the earliest stages of device development, experts said at a
recent audioconference hosted by healthcare research group ECRI.
Roche updated the product label for Tamiflu, adding warnings about the potential for self-injury and delirium in patients using Tamiflu for influenza. Read More